| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 06/12/2008 | US20080139820 Selective tert-butyldimethylsil-protection of 2-(3-Fluoro-4-hydroxyphenyl)-7-vinylbenzooxazol-5-ol at the fluorophenol hydroxyl group using TBSCl/imidazole, sulfating with pyridine-SO3 complex and acidification; 2-(3-Fluoro-4-tert-butyldimethylsilyloxyphenyl)-7-vinylbenzooxazol-5-ol; estrogenic agents |
| 06/12/2008 | US20080139819 Process for the Synthesis of Monosulfated Derivatives of Substituted Benzoxazoles |
| 06/12/2008 | US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
| 06/12/2008 | US20080139633 Estrogen receptor modulators; neurodegenerative disorders; cognitive enhancement |
| 06/12/2008 | US20080139599 e.g. 4-[6-(5-methyl-2-phenyloxazol-4-ylmethoxy)-1-oxoindan-5-yl]benzoic acid; antidiabetic and antilipemic agent, obesity; atherosclerosis; coupling benzene derivatives folowed by hydration and alkylation |
| 06/12/2008 | US20080139547 N-Hydroxyalkynylbenzamide (or hydroxamate) derivatives; anticarcinogenic and antiproliferative agents |
| 06/12/2008 | US20080139481 High binding activity modified peptides; blood stability, receptor selectivity, barrier crossing; N-terminus moieties |
| 06/12/2008 | CA2670285A1 Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
| 06/11/2008 | EP1930322A1 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and ORL1 ligands for the treatment of pain |
| 06/11/2008 | CN101198598A Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 06/11/2008 | CN101195606A Method for synthesizing oxazoline ketone and cyclic urea compounds |
| 06/10/2008 | US7385063 Method for preparing imidazole derivatives |
| 06/10/2008 | US7384965 Fused heterocyclic derivatives as PPAR modulators |
| 06/10/2008 | US7384639 Methods of treating or preventing an infectious disease using an immunogenic conjugate of a gram-negative bacterial autoinducer molecule |
| 06/05/2008 | WO2008067426A1 Process for the synthesis of monosulfated derivatives of substituted benzoxazoles |
| 06/05/2008 | WO2008067425A1 Process for the synthesis of monosulfated derivatives of substituted benzoxazoles |
| 06/05/2008 | US20080132554 Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 06/05/2008 | US20080132543 Therapeutic and Delivery Methods of Prostaglandin Ep4, Agonists |
| 06/05/2008 | US20080132494 Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists |
| 06/05/2008 | US20080132459 Inhibitors of Histone Deacetylase |
| 06/04/2008 | EP0931071B1 Methods of making hiv-protease inhibitors and intermediates for making them |
| 06/04/2008 | CN101193880A Exo- and diastereo- selective syntheses of himbacine analogs |
| 06/04/2008 | CN101193875A Organic metal complex and organic electroluminescent device using same |
| 06/04/2008 | CN101193874A 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming PPAR ligands, methods for production and the use thereof in the form of drugs |
| 05/29/2008 | WO2008064217A2 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and pharmaceutical formulations thereof |
| 05/29/2008 | WO2008063794A2 Oxazolidinium compounds and use as hydrate inhibitors |
| 05/29/2008 | WO2008061308A1 Protein tyrosine phosphatase modulators |
| 05/29/2008 | US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 05/29/2008 | US20080125431 E.g., 3-(2'-Morpholin-4-ylmethyl-biphenyl-4-ylmethyl)-1-oxa-3-aza-spiro[4.5]decan-2-one; acute and chronic neurological and psychiatric disorders and chronic and acute pain disorders; Alzheimer's disease; schizophrenia; antidepressants; bipolar disorders; antiischemic agents; cardiotonic agents |
| 05/29/2008 | US20080125424 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 05/29/2008 | CA2819744A1 Oxazolidinium compounds and use as hydrate inhibitors |
| 05/29/2008 | CA2769571A1 Oxazolidinium compounds and use as hydrate inhibitors |
| 05/28/2008 | EP1924570A1 Azole and thiazole derivatives and their use |
| 05/28/2008 | EP1924554A1 Sulphonamide derivatives |
| 05/28/2008 | EP1924551A2 Organic compounds |
| 05/28/2008 | CN100390135C Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 05/27/2008 | US7378530 Anti-cancer and anti-microbial 5-membered heterocyclic compounds |
| 05/27/2008 | US7378161 Organometallic complexes and organic electroluminescence device using the same |
| 05/22/2008 | WO2008059128A1 Phenylic derivatives and use thereof as drugs |
| 05/22/2008 | WO2008032191A3 Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators |
| 05/22/2008 | WO2008021331A3 Oxazolidone derivatives as pr modulators |
| 05/22/2008 | WO2007104557A3 Novel heterocyclic nf-kb inhibitors |
| 05/22/2008 | US20080119656 Oxazolidinium Compounds and Use as Hydrate Inhibitors |
| 05/22/2008 | US20080119533 New class of antibiotic with potent antibacterial activity against even methicillin resistant Staphylcoccus aureus (MRSA); 3-methylthio-4-phenyl-5-methoxyacetyl-oxazolidin-2-one for example |
| 05/22/2008 | US20080119520 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile |
| 05/22/2008 | US20080119486 Benzoyl-piperazine derivatives |
| 05/22/2008 | US20080119476 Cetp Inhibitors |
| 05/22/2008 | US20080119407 Vitamin D Receptor Modulators |
| 05/21/2008 | EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. |
| 05/21/2008 | EP1482924B1 Cathepsin cysteine protease inhibitors |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/21/2008 | CN101184726A 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 05/20/2008 | US7375136 Such as 1-(4-methanesulphonamidepheoxy)3-(N-methyl-3,4-dichlorophenylethylamino)-2-propanol; synthesis; effective against brain and/or spinal cord tissue acidification disorders |
| 05/20/2008 | US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 05/15/2008 | WO2008055840A1 Thiazole and oxazole-substituted arylamides |
| 05/15/2008 | WO2007034254A8 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 05/15/2008 | US20080114168 Novel esters as useful broad spectrum herbicidal compounds |
| 05/15/2008 | US20080113968 Substituted piperazines and diazepanes |
| 05/15/2008 | CA2668399A1 Thiazole and oxazole-substituted arylamides |
| 05/14/2008 | EP1919883A1 N-oxides as prodrugs of piperazine&piperidine derivatives |
| 05/14/2008 | EP1575922B1 Biphenyl derivatives and their use as fungicides |
| 05/14/2008 | EP1446375B1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents |
| 05/14/2008 | EP1267867B1 Use of prostanoid ep4 receptor antagonists for the treatment of headache and assays for such antagonists |
| 05/14/2008 | CN101177417A Method for preparing herbicide fenoxaprop-p-ethyl |
| 05/14/2008 | CN101177416A (2'S,3'R,4S)-3-[2'-(N-substituted aminomethyl)-3'-hydroxy butyryl]-4-substituted oxazolidin-2-ketone derivative and preparation method thereof |
| 05/14/2008 | CN100387581C Process to produce oxazolidinones |
| 05/14/2008 | CN100387576C Substituted phenylalkanoic acid derivatives and use thereof |
| 05/13/2008 | US7371871 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents, sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents, drug abuse withdrawl |
| 05/13/2008 | US7371777 Such as 2-(3-{[(4-ethoxybenzoyl)amino]methyl}-4-ethoxybenzyl)-tetrahydro-2-furancarboxylic acid; antihyperglycemia and antihyperlipemia action |
| 05/13/2008 | US7371747 Cyanoalkylamino derivatives as protease inhibitors |
| 05/08/2008 | WO2008053913A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 05/08/2008 | WO2008052658A1 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid having improved pharmacological properties |
| 05/08/2008 | WO2007136607A3 Substituted esters as cannabinoid-1 receptor modulators |
| 05/08/2008 | WO2007117591A3 Total synthesis of salinosporamide a and analogs thereof |
| 05/08/2008 | US20080108828 2-t-butyl-4-methyl-1,3-oxazolidine-3,4-dicarboxylic acid 3-t-butyl ester 4-methyl ester; synthetic intermediates in new stereoselective industrial manufacturing methods of optically active alpha , alpha -di-substituted alpha -amino acid and amino alcohol derivatives |
| 05/08/2008 | US20080108678 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; 4-Methylsulfanyl-N-{2-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-acetylamino]-cyclohexyl}-benzamide |
| 05/08/2008 | US20080108675 Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders |
| 05/08/2008 | US20080108609 Benzoxazole Carboxamides For Treating CINV and IBS-D |
| 05/08/2008 | CA2668094A1 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid and having improved pharmacological properties |
| 05/07/2008 | EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain |
| 05/07/2008 | CN101172983A Substituted phenylacetic acids |
| 05/06/2008 | US7368585 Protected trihydroxyisoalkatrienyltriphenylphosphonium halides for proparing polyhydroxylactones; acid stable protecting groups include p-methoxybenzyl and tert-butyldimethylsilyl. |
| 05/06/2008 | US7368578 superior in an adipose tissue weight decreasing action and a retinoid-related receptor function regulating action; to treat obesity, diabetes mellitus, hyperlipidemia, impaired glucose tolerance, hypertension; fewer side effects; 4-{[2-(2-furyl)-1,3-oxazol-4-yl]methoxy}-3-methoxybenzaldehyde |
| 05/06/2008 | US7368572 Anticancer agents |
| 05/06/2008 | US7368415 Substituted beta-(oxazolidin-3-ylcarbonyl)styrenes: 1-[2-(2,4-Dimethyl-cyclohex-3-enyl)-oxazolidin-3-yl]-3-(2-hydroxy-phenyl)-propenone; for delivering fragrances to a laundary detergent, shampoo or hair conditioner |
| 05/02/2008 | WO2007081569A3 Cetp inhibitors |
| 04/29/2008 | US7365207 Process for the production of chiral propionic acid derivatives |
| 04/29/2008 | US7365087 Oxazole derivatives of tetracyclines |
| 04/29/2008 | US7365084 Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals |
| 04/29/2008 | US7365074 Pyridazine, pyrimidine and pyrazine ethyne compounds |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/28/2008 | CA2666880A1 Organic compounds |
| 04/24/2008 | WO2007081571A3 Cetp inhibitors |
| 04/24/2008 | WO2007075870A3 Processes for taxane derivatives and intermediates useful therein |
| 04/24/2008 | WO2007032028A8 Thiazolinones and oxazolinones and their use as ptp1b inhibitors |
| 04/24/2008 | US20080096942 Beta-secretase inhibitors; use in treating Alzheimer's disease; for example, N-{(1S,2R)-1-[3-(cyclohexylmethyl)benzyl]-2-hydroxy-3-[(3-methoxybenzyl)amino]propyl}acetamide hydrochloride |
| 04/24/2008 | US20080096937 For example, 2-{4-[(2-chloro-benzyl)-ethyl-amino]-phenyl}-1,1,1,3,3,3-hexafluoro-propan-2-ol; the compounds bind to and selectively activate LXR alpha and LXR beta; used to treat diseases such as atherosclerosis and diabetes |
| 04/23/2008 | EP1914225A1 Salt molten at room temperature and display device |
| 04/23/2008 | EP1912982A2 Novel heterocyclic nf- b inhibitors |
| 04/23/2008 | EP1912958A1 Substituted malononitrile compounds for combating animal pests |